Please login to the form below
e-Therapeutics
This page shows the latest e-Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Doctors worried NHS is unprepared for coronavirus as government unveils action plan
March. Doctors raised concerns around a lack of intensive care and high-dependancy beds, poor staffing levels, lack of personal protective equipment and inappropriate advice to attend A&E/GP practices ... Compared to therapeutics – i.e. targeted
Latest news
-
e-Therapeutics raises £40m to support oncology pipeline
UK biopharma company e-Therapeutics will raise about £40m ($62m) from a recapitalisation programme that will help fund phase II development of its lead cancer drug. ... e-Therapeutics identified the drug's potential in cancer using its network
-
New leadership for Halozyme
Halozyme Therapeutics, the San Diego-based enzyme therapy developer that in October realigned its research priorities and cut its workforce by 25 per cent, has appointed Gregory I Frost to serve ... Halozyme Therapeutics, whose partners include Roche and
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest appointments
-
Paul Stockdale joins Oxford BioDynamics as CFO
Stockdale arrives at the company from e-Therapeutics, where he had been financial controller since 2012, and has also previously served at Deloitte as a senior manager.
-
e-Therapeutics appoints new CEO
Dr Raymond Barlow joins firm from Amgen. UK-based drug discovery and development firm e-Therapeutics appoints Dr Raymond Barlow as its new CEO. ... He said: “e-therapeutics is at the forefront of a new wave of science and has created a unique,
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- New Playbook Alert: Virtual Patient Engagement
- AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition
- UK Biobank reveals new data from world's largest genetic project
- New study finds dose of Mavenclad treatment could predict MS relapse risk
- Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant
- GSK global survey reveals misunderstandings about shingles in adults
No results were found
PMHub
Medscape Medical Affairs
Medscape Medical Affairs enables all medical affairs professionals to take a more strategic leadership role, and maximize the impact of...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
